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Glucocorticoids rapidly regulate synaptic input to neuroendocrine cells in the hypothalamic
paraventricular nucleus (PVN) by inducing the retrograde release of endogenous messen-
gers. Here we investigated the rapid effects of dexamethasone (DEX) on excitatory synaptic
input to feeding-related, preautonomic PVN neurons using whole-cell patch-clamp record-
ings. In ∼50% of identified gastric-related preautonomic PVN neurons, DEX elicited a
biphasic synaptic response characterized by an initial rapid and transient increase in the
frequency of miniature excitatory postsynaptic currents (mEPSCs), followed by a decrease
in mEPSC frequency within 9 min; remaining cells displayed only a decrease in mEPSC
frequency. The late-phase decrease in mEPSC frequency was mimicked by the cannabi-
noid receptor agonists anandamide (AEA) and WIN 55,212-2, and it was blocked by the
CB1 receptor antagonist AM251.The biphasic DEX effect was mimicked by AEA.The early
increase in mEPSCs was mimicked by activation of transient receptor potential vanilloid
type 1 (TRPV1) receptors with capsaicin and by activation ofTRPV4 receptors with 4-α-PDD.
The increase was reduced, but not blocked, by selective TRPV1 antagonists and in TRPV1
knockout mice; it was blocked completely by the broad-spectrum TRPV antagonist ruthe-
nium red and by combined application of selectiveTRPV1 andTRPV4 antagonists.The DEX
effects were prevented entirely by intracellular infusion of the G-protein inhibitor, GDPβS.
Thus, DEX biphasically modulates synaptic glutamate onto a subset of gastric-related PVN
neurons, which is likely mediated by induction of a retrograde messenger. The effect
includes a TRPV1/4 receptor-mediated transient increase and subsequent CB1 receptor-
mediated suppression of glutamate release. Multiphasic modulation of glutamate input to
PVN neurons represents a previously unappreciated complexity of control of autonomic
output by glucocorticoids and endogenous cannabinoids.
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INTRODUCTION
The paraventricular nucleus (PVN) of the hypothalamus plays
a critical role in integrating neural and humoral signals leading
to the coordination of neuroendocrine and autonomic motor
outputs. Preautonomic PVN neurons control sympathetic and
parasympathetic output via projections to the brainstem and
spinal cord (Swanson and Kuypers, 1980). Anatomical and phys-
iological evidence suggests that PVN neurons are involved in
controlling energy homeostasis, including regulation of feeding
behavior and digestion (Sims and Lorden, 1986). In general, inhi-
bition of PVN neuron activity tends to induce feeding, whereas
a reduction in feeding is associated with increased PVN activity
(Kow and Pfaff, 1989). This is presumably mediated in large part by
neural interactions with brainstem autonomic nuclei that regulate
output to the stomach. Modulation of hypothalamic-brainstem
circuit activity likely plays a key role in regulating feeding behavior.
Glucocorticoids can affect the hypothalamic-pituitary-adrenal
(HPA) axis and also regulate feeding behavior (Tempel et al.,
1993; Dallman, 2003; Di et al., 2003). Recent findings indicate
that glucocorticoids elicit a rapid inhibitory response in the PVN
by inducing retrograde release of the endogenous cannabinoids
(eCBs) 2-arachidonoyl glycerol (2-AG) and anandamide (AEA)
from parvocellular and magnocellular neuroendocrine cells (Di
et al., 2003, 2005b). These eCBs act to inhibit glutamate release,
leading to a reduced excitatory synaptic drive to PVN neuroen-
docrine cells over the course of a few minutes (Di et al., 2005b).
Cannabinoid actions in the brain are largely mediated through
CB1 receptors, but AEA also activates TRPV1 in transfected cells
(Zygmunt et al., 1999; Van Der Stelt and Di Marzo, 2004). Whereas
CB1 receptors are G-protein-coupled receptors and their bind-
ing typically inhibits synaptic release, TRPV1 are ligand-coupled
non-specific cation channels, whose activation at synaptic termi-
nals typically increases transmitter release (Marinelli et al., 2003;
Tominaga and Tominaga, 2005; Caterina, 2007). We recently iden-
tified dual inhibitory and excitatory effects of exogenously applied
AEA on synaptic input to preautonomic neurons in the dorsal
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motor nucleus of the vagus, an effect that was mediated by bind-
ing to CB1R and TRPV1, respectively (Derbenev et al., 2004, 2006).
TRPV1 receptors are expressed in the PVN (Cristino et al., 2006),
and their activation appears to potentiate glutamatergic signals
to PVN neurons that project to the spinal cord (Li et al., 2004).
Recently, TRPV2 and TRPV4 were also identified in the hypothal-
amus (Guler et al., 2002; Wainwright et al., 2004; Cristino et al.,
2006). Like TRPV1, TRPV4 can also be modulated by eCBs (Guler
et al., 2002; Watanabe et al., 2003; Wechselberger et al., 2006).
However, TRPV-mediated effects of eCBs have not previously been
identified in PVN neurons.
Glucocorticoids applied in the PVN cause the release of eCB
ligands from neuroendocrine PVN cells (Di et al., 2005b; Evanson
et al., 2010). Since both CB1R and TRPV1 are functional in the
PVN, and AEA is an agonist at both receptors and at TRPV4, we
hypothesized that glucocorticoid-mediated eCB release activates
both TRPV and CB1 receptors on presynaptic afferent terminals
in PVN. Because of the known link between eCB activity and
ingestive/digestive behaviors, we tested for DEX-induced mod-
ulation of miniature excitatory postsynaptic currents (mEPSCs)
in gastric-related preautonomic PVN neurons identified by ret-
rograde transsynaptic labeling from the stomach with pseudora-
bies virus (PRV) 152 (PRV-152), which expresses enhanced green
fluorescent protein (EGFP).
MATERIALS AND METHODS
ANIMALS
Male (4–8 weeks old) Sprague Dawley rats (Harlan, Indianapolis,
IN, USA) and female and male B6.129× 1-Trpv1tm1Jul/J homozy-
gote mice (6–19 weeks old a gift of Dr. Y. Lee, bred from founders
obtained from The Jackson Laboratory, Bar Harbor, ME, USA)
were used for these experiments. Animals were housed in a vivar-
ium under 12 h light, 12 h dark cycle with food and water available
ad libitum. The University of Kentucky Animal Care and Use
Committee approved all animal procedures.
RETROGRADE TRANSSYNAPTIC NEURONAL TRACING
A PRV strain isogenic with the attenuated PRV Bartha, which was
constructed to report EGFP (PRV-152; a gift from L. W. Enquist,
Princeton University) was used to retrogradely label neurons that
were synaptically connected to the gastric musculature (Smith
et al., 2000; Davis et al., 2003; Glatzer et al., 2003; Derbenev et al.,
2004, 2006). Under isoflurane anesthesia, rats were inoculated with
PRV-152 (1× 108 pfu/ml) directed tangentially into the muscula-
ture of the greater curvature of the stomach fundus (2µL; 3–4
injections per stomach) using a Hamilton syringe fitted with a
26-gage needle. Each injection was made over the course of 30 s
and the needle remained in place for 1 min after injection. The
abdominal compartment was rinsed thoroughly with sterile saline
to prevent accidental labeling of other viscera (Glatzer et al., 2003;
Derbenev et al., 2004, 2006). The abdominal wall was then sutured;
animals recovered and were maintained in a biosafety level 2 labo-
ratory for up to 96 h post-injection. The PRV-152 infects terminal
fields in the stomach wall and selectively labels preautonomic cen-
tral neurons retrogradely in synaptic series. Because it does not sort
in axons or glial cells, the construct does not spread orthogradely or
non-specifically from axons to other structures (Ch’ng et al., 2007).
Labeling sequence, timing, and other characteristics have been
well-characterized for this pathway and include initial appearance
of EGFP in the PVN at about 72 h post-inoculation, with numbers
of labeled cells peaking by 96 h (i.e., <24 h after initial neuron
infection in the PVN). Central neurons infected for up to 72 h
display no apparent adverse effects of viral infection (Smith et al.,
2000; Irnaten et al., 2001; Davis et al., 2003; Glatzer et al., 2003,
2007; Derbenev et al., 2004), but this was verified in the PVN,
where typical measurements of membrane potential, input resis-
tance, action potential generation, and presence of low-threshold
spikes indicative of preautonomic PVN cells were obtained (Luther
and Tasker, 2000; Stern, 2001; Luther et al., 2002).
PVN SLICE PREPARATION
Acute hypothalamic slices containing the PVN were prepared
from infected male Sprague Dawley rats and TRPV1 knockout
mice. Animals were deeply anesthetized with halothane inhala-
tion (Sigma, St. Louis, MO, USA) and then decapitated. The brain
was removed from the cranial cavity after cutting the optic nerves
and immersed in an ice-cold (0–4˚C) artificial cerebral spinal fluid
(aCSF) bubbled with 95% O2–5% CO2. The composition of aCSF
was (in mM): 124 NaCl, 3 KCl, 26 NaHCO3, 1.4 NaH2PO4, 11
glucose, 1.3 CaCl2, and 1.3 MgCl2; pH 7.3–7.4. The hypothala-
mus was blocked and glued onto a metal stage and 300µm slices
were cut with a vibratome. The slices were transferred to a holding
chamber and incubated in oxygenated aCSF at room temperature
for 1 h before being transferred to a recording chamber mounted
on the fixed stage of an upright microscope (BX51WI; Olympus,
Melville, NY, USA).
WHOLE-CELL RECORDINGS
Whole-cell patch-clamp recordings were performed under visual
control on an upright, fixed stage microscope equipped with
infrared illumination and differential interference contrast (IR-
DIC) and epifluorescence illumination to identify EGFP-labeled
cells (Olympus BX51WI). Epifluorescence was briefly used to tar-
get EGFP-labeled cells, at which time the light source was switched
to IR-DIC to obtain the recording. Gastric-related preautonomic
neurons were identified as EGFP-labeled as previously described
(Smith et al., 2000; Glatzer et al., 2003) by visualization under
fluorescence microscopy and were filled with biocytin during
recordings for post hoc visualization with avidin-Texas Red.
For whole-cell patch-clamp recordings, electrodes (2–5 MΩ)
were filled with a solution containing the following (in mM): 130
Cs+-gluconate, 1 NaCl, 5 EGTA, 10 HEPES, 1 MgCl2, 1 CaCl2,
3 CsOH, 2–3 Mg-ATP, and 0.2% biocytin, pH 7.3–7.4, adjusted
with 5 M CsOH. For current-clamp recordings, K+-gluconate was
used in the recording pipette. To test whether these responses
depended on G-protein activity in the recorded cell, a subset of
neurons was recorded using pipettes containing guanosine 5′[β-
thio]diphosphate trilithium salt (GDPβS; 500µM, Sigma-Aldrich,
St. Louis, MO, USA). Excitatory postsynaptic currents (EPSCs)
were examined at a holding potential of −60 mV. Electrophysio-
logical signals were recorded using an Axoclamp 700B amplifier
(Molecular Devices, Union city, CA, USA), low-pass filtered at
2 kHz, and stored to a computer using a digidata 1440A A-D con-
verter and pClamp 10.2 software (Molecular Devices, Union City,
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CA, USA). Synaptic currents were analyzed offline using pClamp
10.2 and MiniAnalysis 6.0.3. (Synaptosoft, Decatur, CA, USA).
DRUG APPLICATION
All experiments were performed with tetrodotoxin (TTX, 1µM)
in the aCSF solution to block action potentials and isolate mEP-
SCs, with the exception of on-cell recordings of firing activity.
Dexamethasone (DEX, 10µM; Sigma, St. Louis, MO, USA) and
ruthenium red (RR, 1µM; Tocris, Ellisville, MO, USA) were dis-
solved in aCSF; capsaicin (CP, 0.1, 1, 10µM), capsazepine (CPZ,
10µM), 5′-iodoresiniferatoxin (5′-iRFT, 1µM; Tocris Bioscience,
Ellisville, MO, USA), and 4α-phorbol 12,13-didecanoate (4-α-
PDD, 1µM; Alexis Biochemicals, San Diego, CA, USA) were
dissolved in ethanol and diluted in aCSF (final concentration
of ethanol <0.01% by volume). WIN 55,212-2 (10µM, Sigma),
RN1743 (10µM; Tocris), and AM251 (10µM; Tocris) were dis-
solved in DMSO and diluted in aCSF. AEA (10µM) was purchased
as predissolved stock in Tocrisolve (Tocris). Vehicle alone had no
effect on membrane or synaptic properties (Derbenev et al., 2006).
DATA ANALYSIS
Baseline (control) mean frequency and amplitude of mEPSCs
were obtained over a 3 min period just prior to drug applica-
tion. Measurements of drug effects within a given recording were
assessed from the average of the first 3 min after drug application
(i.e., 0–3 min after the drug equilibrated in the recording cham-
ber; i.e., 3 min time point) and during min 6–9 (i.e., 9 min time
point) of drug application. The effect of agonists and antago-
nists on mEPSC frequency and amplitude were analyzed using a
repeated-measures ANOVA comparing control to segments exam-
ined 0–3 and 6–9 min after agonist application. When appropriate,
Tukey’s post hoc test was used to determine significance. The non-
parametric, intra-assay Kolmogorov–Smirnov test (K–S test;>150
events per condition) was also used initially to objectively deter-
mine if a given cell demonstrated a change in mEPSC frequency
or amplitude during the first 3 min of drug application. A prob-
ability of <0.02 was considered significant for K–S analyses. In
the population in which it was detected, the magnitude of change
was assessed using a paired one-tailed Student’s t -test, where indi-
cated. All other comparisons of single-variable grouped data were
performed using paired, two-tailed Student’s t -test. Probability
values< 0.05 were considered significant for grouped data. Values
are reported as the mean± SEM.
RESULTS
IDENTIFICATION AND MEMBRANE PROPERTIES OF GASTRIC-RELATED
PRV-152-LABELED NEURONS
Expression of EGFP in PVN neurons was observed beginning 72 h
after PRV-152 inoculation of the stomach. Gastric-related preau-
tonomic neurons labeled with EGFP were targeted for recording
72–96 h after inoculation (Figures 1A–E), a time window dur-
ing which the electrophysiological properties of PRV-152-infected
neurons were demonstrated previously to be unaffected by the
virus (Smith et al., 2000; Glatzer et al., 2003, 2007). To confirm
their identity as EGFP-labeled, gastric-related neurons and their
location in PVN, a subset of recorded neurons was filled with bio-
cytin and visualized post hoc with an avidin-Texas Red or avidin-
rhodamine conjugate and/or an ABC-DAB reaction (Figure 1).
Action potential firing and membrane properties of EGFP-labeled
PVN neurons (Figures 1F,G) were examined and were found to be
similar to those reported previously for PVN preautonomic neu-
rons (Stern, 2001; Luther et al., 2002). Electrophysiological char-
acteristics of gastric-related preautonomic PVN neurons included
four basic firing patterns, including tonic regular, tonic irregu-
lar, bursting, and silent (Figure 1F, silent cells not presented),
consistent with previous analyses of retrogradely labeled preau-
tonomic and neuroendocrine PVN neurons (Stern, 2001; Luther
et al., 2002). The presence of low-threshold spikes in response
to depolarizing current pulses (70–90 pA) from a hyperpolarized
membrane potential (−80 to −90 mV) was also observed, sug-
gesting the activation of low-voltage activated calcium channels
(Figure 1G).
BIPHASIC EFFECT OF DEX ON mEPSC FREQUENCY
Glucocorticoids were recently demonstrated to induce the ret-
rograde release of eCBs from magnocellular and parvocellular
neuroendocrine PVN neurons, leading to a presynaptic, CB1R-
mediated reduction in mEPSC frequency within minutes of drug
application (Di et al., 2003, 2005b). Here, mEPSCs were recorded
to investigate the rapid effect of the synthetic glucocorticoid
dexamethasone (DEX) on spike-independent glutamate release
onto gastric-related preautonomic PVN neurons. Gastric-related
preautonomic parvocellular PVN neurons demonstrated a signif-
icant decrease in mEPSC by 9 min of DEX application (Tukey’s;
p= 0.0008; n= 11; Figure 2). Under control conditions, the aver-
age mEPSC frequency for all cells was 3.1± 0.8 Hz (n= 11) and
ranged from 1.2 to 11.0 Hz. After 10µM DEX application, the
mean frequency of mEPSCs was decreased to 2.1± 0.6 Hz (range
0.7–7.4 Hz). The decrease in frequency at 9 min was detected in
each of the 11 neurons. However, we also examined individual
responses from 15 neurons during the first 3 min of DEX applica-
tion and determined that 40% of the gastric-related preautonomic
PVN neurons exhibited a significant increase in mEPSC frequency
shortly after agonist application (K–S test; p< 0.02). Thus, in 6
out of 15 gastric-related preautonomic cells (40%), DEX-induced
a rapid and transient increase in the mEPSC frequency within
the first 3 min of drug exposure. Under control conditions, the
average mEPSC frequency in these six neurons was 1.3± 0.2 Hz
(range 0.9–1.8 Hz). The mean mEPSC frequency over the first
3 min DEX application (10µM) increased to 2.0± 0.2 Hz (range
1.2–2.4 Hz; p< 0.05; paired t -test; n= 6; Figure 2). There was no
correlation between the control mEPSC frequency in a given cell
and the relative change in frequency subsequent to DEX applica-
tion at either the 3 min (R= 0.0006) or 9 min (R= 0.0604) time
points. There was no significant change in mEPSC amplitude dur-
ing DEX application; the average amplitude before application
of DEX was 11.5± 1 pA and after bath application of DEX was
10.4± 1 pA (n= 11; p> 0.05). Thus, whereas DEX application
reduced mEPSC frequency in all neurons tested, this reduction was
preceded by a transient enhancement in frequency in a large subset
of neurons. In five neurons, mEPSC frequency was also examined
12–15 min after returning to normal ACSF to determine if the
changes in mEPSC frequency were reversible. Return of mEPSC
frequency to control levels 15 min after DEX application was
apparent in only one cell, so recovery was not further examined.
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FIGURE 1 | PRV-152-infected gastric-related preautonomic neuron
recorded in the PVN. (A) Fluorescence micrograph of a PVN slice (300µm)
showing EGFP-labeled, gastric-related preautonomic neurons approximately
90 h after PRV-152 inoculation of the stomach. (B) Example of a PVN neuron
that was recorded in the slice preparation. Arrow indicates to recording
pipette. (C)The same neuron as in (B) illuminated with epifluorescence
indicating it contained GFP. (D) Image of a slice from which a GFP-labeled
PVN neuron was recorded. The arrow indicates the recorded cell. (E)
Fluorescence image of the recorded cell [same as in (D)] filled with biocytin
and visualized with an Avidin-Texas Red conjugate. (F) Loose-patch recordings
of action potential activity demonstrating typical firing patterns in three
PRV-152 labeled, gastric-related PVN neurons. (G) Current-clamp recording
from a gastric-related preautonomic neuron that generated a low-threshold
spike (arrow) in response to depolarizing current pulses (70–90 pA) from a
membrane potential of −90 mV [same neuron as shown in (D,E)]. III, third
ventricle.
BIPHASIC EFFECT OF ANANDAMIDE ON mEPSC FREQUENCY
The effects of eCB agonists have been shown to involve cannabi-
noid (Di et al., 2003, 2005b) and/or vanilloid receptor activation
(Derbenev et al., 2004, 2006) when these receptors are present cen-
trally. Since the rapid glucocorticoid actions on glutamate release
onto PVN neuroendocrine cells are mediated by eCB synthesis and
retrograde release (Di et al., 2003, 2005b), we tested for the eCB-
dependence of the biphasic DEX modulation of mEPSC frequency
in gastric-related preautonomic PVN neurons. Similar to the DEX
effect, bath application of 10µM AEA biphasically altered mEPSC
frequency (Figure 3). In the presence of AEA, all observed PVN
cells demonstrated a decrease in mEPSC frequency by 9 min com-
pared to both control and 3 min as determined by a Tukey’s post hoc
(n= 9; p< 0.0001). The frequency of mEPSCs in control condi-
tions for all neurons tested was 4.9± 0.7 Hz (range 1.5–8.1 Hz;
n= 9). After a 9 min application of AEA (10µM), the mEPSC
frequency decreased to 3.4± 0.6 Hz (range 0.8–6.3 Hz; p< 0.001;
Tukey’s; Figure 3E), which was similar to the inhibition of mEPSCs
reported in PVN parvocellular and magnocellular neuroendocrine
cells (Di et al., 2003, 2005b). Responses to AEA application within
11 individual cells revealed a subset of PVN neurons that demon-
strated a rapid increase in mEPSC frequency (p< 0.02). The rapid,
transient increase in mEPSC frequency was observed in 5 out of
11 gastric-related preautonomic cells (45%) in the first 3 min of
the drug application (Figure 3). The average basal mEPSC fre-
quency in these cells was 3.8± 1.2 Hz (range 0.8–7.6 Hz). After
application of AEA (10µM), the mean frequency of mEPSCs was
increased to 5.2± 1.0 Hz (range 2.5–8.4 Hz; n= 5; p< 0.03; paired
one-tailed t -test). There was no significant change in the mEPSC
amplitude after application of AEA. The average amplitude before
application of AEA was 14± 1 pA (range 9–19 pA; n= 11) and
after 9 min application of AEA was 13.7± 1.2 pA (range 7–19 pA;
p> 0.05). There was no correlation between the control mEPSC
frequency in a given cell and the relative increase in frequency sub-
sequent to AEA application at either the 3 (R= 0.1076) or 9 min
(R= 0.1709) time points. The frequency of mEPSCs was therefore
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FIGURE 2 | Rapid biphasic changes in mEPSC frequency in PVN
gastric-related preautonomic neurons elicited by dexamethasone
(DEX). (A–C) Sequential recordings of mEPSCs observed in an
EGFP-labeled PVN neuron at a holding potential of −60 mV in control
conditions (A) and after 3 min (B) and 9 min (C) of bath application of
10µM DEX. Bottom traces show the boxed areas in the upper traces on
an expanded time scale. (D) Cumulative probability plots of inter-mEPSC
interval distribution from the same cell showed a significant increase at
3 min (leftward shift) and a significant decrease at 9 min (rightward shift) in
mEPSC frequency (K–S test, p< 0.02). (E) Mean group changes in mEPSC
frequency caused by 10µM DEX at 3 and 9 min (n= 11; ANOVA, Tukey’s;
*p<0.05 from control). (F) Mean group frequency changes in the subset
of neurons in which the K–S test detected an increase in mEPSC
frequency (n=6; *p<0.05, t -test).
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FIGURE 3 | Anandamide biphasically altered mEPSC frequency in
gastric-related preautonomic neurons. (A–C) Sequential recordings of
mEPSCs observed in EGFP-labeled PVN neurons at a holding potential of
−60 mV in control conditions (A) and after 3 min (B) and 9 min (C) of bath
application of 10µM AEA. Bottom traces show the boxed areas in the upper
traces on an expanded time scale. (D) Cumulative probability plots of
inter-mEPSC interval distribution from the same cell showed a significant
increase at 3 min (leftward shift) and a significant decrease at 9 min (rightward
shift) in mEPSC frequency (p<0.02; K–S test). (E) Pooled data from all tested
cells showing changes in frequency of mEPSCs caused by 10µM AEA at 3
and 9 min (n=9; *p<0.05 from control and 3 min; ANOVA, Tukey’s). (F)
Pooled data from the subset of neurons that responded to AEA with an
increase in mEPSC frequency (45%) showing changes in the frequency of
mEPSCs at 3 min (n=5; * p<0.05, t -test).
biphasically altered by AEA in a subset of neurons, but the over-
all effect was a decrease in mEPSC frequency by 9 min of AEA
application.
CB1 RECEPTOR DEPENDENCE OF DEX AND AEA EFFECT
To determine if CB1 receptors participated in the DEX and AEA
inhibition of mEPSC frequency, DEX and AEA were applied in the
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presence of the CB1R antagonist AM251 (10µM). The mEPSC
frequency was unaffected by AM251 alone, but the decrease in
mEPSC frequency induced by DEX (10µM) or AEA (10µM)
at 10 min was prevented by the antagonist. In the presence of
AM251, a rapid increase in mEPSC frequency was observed after
application of DEX or AEA. Bath application of 10µM DEX in the
presence of AM251 increased mEPSC frequency from 6.6± 2.1 Hz
(range 2.9–12.2 Hz) to 8.7± 2.6 Hz (range 4.4–15.4 Hz; p< 0.05;
paired t -test) in four out of seven cells during the first 3 min
(57%; Figure 4B), while the mEPSC frequency in the remain-
ing three cells was unaffected. However, no cell demonstrated a
decrease in mEPSC frequency at either early or later time peri-
ods (Tukey’s, p= 0.12; Figure 4A). Similarly, bath application of
10µM AEA in the presence of AM251 increased mEPSC frequency
from 2.8± 0.6 Hz (range 2.0–4.1 Hz) to 4.3± 0.6 Hz (range 3.6–
5.7 Hz; p< 0.02; paired t -test) in three out of seven cells (43%),
but a decrease in mEPSC frequency was not detected during AEA
application (Tukey’s, p= 0.58). Whereas the decrease in mEPSC
frequency was blocked by the CB1 receptor antagonist, the tran-
sient increase in mEPSC frequency caused by DEX or AEA in a
subset of neurons was not prevented.
The high-affinity synthetic cannabinoid agonist WIN 55,212-2
(WIN) decreased the mEPSC frequency in preautonomic par-
vocellular neurons. The K–S test did not detect a subset of
neurons in which mEPSC frequency increased. Rather bath
application of 10µM WIN decreased mEPSC frequency in all
cells tested measured by 9 min from 1.1± 0.3 Hz (range 0.4–
3.4 Hz) to 0.6± 0.2 Hz (range 0.4–1.8 Hz; p< 0.04; Tukeys; n= 8;
Figure 4C); there was no change in frequency in any recording at
the earlier time point (p> 0.05). The inhibitory effect of DEX on
mEPSC frequency was thus prevented by a CB1 receptor antago-
nist and mimicked by a CB receptor agonist. It was likely mediated,
therefore, by the release of an eCB, similar to the effect described
previously in PVN neuroendocrine cells (Di et al., 2003, 2005b).
TRP RECEPTOR DEPENDENCE OF DEX AND AEA EFFECT
Anandamide is an agonist at TRPV1 (Di Marzo et al., 1994; Zyg-
munt et al., 1999) and effects of the TRPV1 agonist capsaicin
have been reported previously in parvocellular PVN cells (Li et al.,
2004). We hypothesized that the DEX- and AEA-induced tran-
sient increases in mEPSC frequency in preautonomic neurons
were caused by the activation of TRPV receptors in the PVN.
To determine if the rapid, transient increase in mEPSC frequency
could be mimicked by a TRPV1 agonist other than AEA, the effect
of capsaicin was investigated in PRV-152 labeled, gastric-related,
preautonomic PVN neurons. Within 3 min of application, cap-
saicin increased the frequency of mEPSCs in EGFP-labeled preau-
tonomic neurons. Bath application of 100 nM capsaicin increased
mEPSC frequency in one neuron (i.e., by K–S test) but had no
significant overall effect on the mEPSC frequency. Baseline fre-
quency was 3.5± 0.9 Hz (range 0.8–4.9 Hz) and was 3.8± 1.0 Hz
in 100 nM capsaicin (range 0.8–5.4 Hz; p> 0.05; two-tailed, paired
t -test; n= 4). Application of 1µM capsaicin increased signifi-
cantly the frequency of mEPSCs in four of five neurons. Mean
frequency was increased significantly in this group of cells, from
3.3± 1.0 Hz (range 1.3–6.5 Hz) to 5.2± 0.9 Hz (range 3.0–7.9 Hz;
p< 0.05; n= 5). Application of 10µM capsaicin increased mEPSC
frequency in seven of eight neurons. Mean frequency was increased
from 4.5± 1.1 Hz (range 0.8–7.7 Hz) to 8.3± 1.8 Hz (range 0.9–
13.5 Hz; p< 0.05; n= 8). There was no correlation between the
control mEPSC frequency in a given cell and the relative increase in
frequency subsequent to capsaicin application (R= 0.1416). There
was no significant change in mEPSC amplitude after application
of any concentration of capsaicin (p> 0.05).
Application of the broad-spectrum TRPV antagonist ruthe-
nium red (1µM) blocked completely the rapid increase in mEPSC
frequency caused by DEX (10µM; n= 5), capsaicin (1µM; n= 5)
and AEA (10µM, n= 8; Table 1) in gastric-related PVN neu-
rons. In the presence of ruthenium red, DEX (10µM) induced
a 15± 6% decrease in mEPSC frequency instead of an increase
at 3 min (compare to 53± 10% increase, Figure 2F), which then
progressed to a 37± 6% decrease in mEPSC frequency by 9 min
(p< 0.05; ANOVA, Tukey’s; n= 5); the decrease in mEPSC fre-
quency at 9 min was similar to that seen in the absence of ruthe-
nium red. Application of capsaicin (1µM) was without effect
in the presence of ruthenium red (p> 0.05; n= 5; Table 1).
0
2
4
6
8
10
12
14
m
E
P
S
C
F
re
q
u
e
n
c
y
(H
z
)
A
M
25
1
D
E
X
3
m
in D
E
X
9
m
in
0
2
4
6
8
10
12
A
M
25
1
D
E
X
3
m
in
0
0.5
1
1.5
2
C
on
tro
l
W
IN
3
m
in W
IN
9
m
in
m
E
P
S
C
F
re
q
u
e
n
c
y
(H
z
)
BAll CellsA Cells with Increases C
*
*
m
E
P
S
C
F
re
q
u
e
n
c
y
(H
z
)
FIGURE 4 | CB1 receptor dependence of dexamethasone (DEX)-induced
suppression of mEPSC frequency. (A) In the presence of the CB1 receptor
antagonist (AM251; 10µM), DEX did not elicit a significant decrease in
mEPSC frequency (n=6; ANOVA, Tukey’s). (B) In AM251, DEX increased
mEPSC frequency in a subset of neurons. The graph illustrates the mean
frequency change in cells in which an increase in mEPSC frequency was
detected (n=4; *p<0.05, t -test). (C)The synthetic cannabinoid agonist, WIN
55,212-2 (WIN; 10µM) decreased the frequency of mEPSCs (n= 8; *p<0.05
from control; ANOVA, Tukey’s); an increase in mEPSC frequency was not
observed at either the early or late time point in the presence of WIN.
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Table 1 | Percent of cells responding with an increase in mEPSC frequency and percent frequency change due to DEX,AEA, and capsaicin after
TRPV receptor block.
DEX (10µM) AEA (10µM) Capsaicin (1µM)
% Responding
cells
% Frequency
change
% Responding
cells
% Frequency
change
% Responding
cells
% Frequency
change
Control 40 (15) 53±10 45 (11) 103±72 80 (5) 113±39
TRPV1 KO – – – – 57 (7) 36±18
TRVP1 antagonist 40 (10) 32±13 50 (10) 62±34 64 (14) 92±33
TRPV1+TRPV4 antagonist 0 (5) 3±4 – – – –
Ruthenium red 0 (6) −6±4 0 (6) −11±2 0 (5) −13±13
Numbers in parenthesis indicate total number of cells examined. AEA, anandamide; DEX, dexamethasone.
Ruthenium red prevented the rapid increase in mEPSC frequency
by AEA in the first 3 min (Table 1), but did not affect the decrease
in mEPSC frequency at 9 min (32± 9%; p< 0.05, n= 6). Ruthe-
nium red (1µM) alone had no effect on the baseline frequency of
mEPSCs in any of four cells tested. It prevented the rapid, tran-
sient increase in mEPSC frequency caused by DEX, capsaicin, and
AEA, whereas the later inhibition of mEPSCs by DEX and AEA was
not blocked. These data implicated the involvement of a receptor
from the TRPV family in the excitatory effect of DEX and AEA on
mEPSC frequency (Table 1).
To identify the possible receptor(s) mediating the rapid facil-
itatory effect of AEA, DEX, and capsaicin on mEPSC frequency,
selective antagonists to TRPV1 were applied prior to application
of capsaicin (1µM), AEA (10µM), and DEX (10µM). A 15 min
preapplication of neither the selective TRPV1 receptor antagonist
capsazepine (10µM) nor the potent TRPV1 antagonist 5′-iRFT
(1µM) blocked completely the excitatory effect of capsaicin, AEA,
or DEX. The K–S test revealed a significant capsaicin-mediated
increase in mEPSC frequency in four out of seven cells in the
presence of 5′-iRFT (p< 0.05; Table 1). An increase in mEPSC
frequency (62± 34%) induced by AEA (10µM) was also seen in 5
of 10 cells in the presence of 5′-iRFT (p< 0.05). In addition, DEX
(10µM) increased mEPSC frequency (32± 13%) in 4 of 10 cells in
the presence of capsazepine (10µM, p< 0.05; K–S test; Table 1),
while capsaicin (1µM) increased mEPSC frequency in five of
seven cells (Table 1). The percentage of neurons that responded
to AEA and DEX application was similar in control conditions
(∼50%) and in the presence of TRPV1 antagonist (∼50%), but
the magnitude of the increase observed under control conditions
(53± 10% for DEX; 102± 78% for AEA) was greater than that
observed in the presence of the antagonist (32± 13% for DEX;
62± 34% for AEA), suggesting that a portion (∼50%) of the ago-
nist activity was due to activation of TRPV1 (Table 1). In addition
to capsaicin-induced TRPV1-mediated effects in PVN (Li et al.,
2004), a non-TRPV1-mediated increase in mEPSC frequency was
also elicited by capsaicin, AEA, and DEX when TRPV1 receptors
were blocked.
TRPV1 KNOCKOUT MICE
To verify that the capsaicin-mediated increase in mEPSC frequency
was mediated by receptors other than TRPV1 and was not simply
a result of agonists “outcompeting” antagonists, we determined
the effect of capsaicin on mEPSCs in gastric-related PVN neurons
in slices from TRPV1 knockout mice (B6.129× 1-Trpv1tm1Jul/J
homozygote). Absence of the nociceptive wiping response to ocu-
lar application of a capsaicin solution (200µM) was used to verify
the absence of TRPV1 functionality in the knockout mice (Gamse,
1982). Bath application of capsaicin (1µM) significantly increased
the frequency of mEPSCs in four out of seven cells from TRPV1
knockout mice within 3 min of application, from 2.9± 0.8 Hz
(range 1.6–5.2 Hz) in control to 3.8± 0.8 Hz in capsaicin (range
2.4–5.8 Hz; p< 0.05; n= 4; Table 1).
Dexamethasone application resulted in a ruthenium red-
sensitive enhancement of mEPSC frequency that was reduced,
but was not blocked by selective TRPV1 antagonists. To deter-
mine if the DEX-induced changes in mEPSC frequency involved
activation of TRPV4 in addition to TRPV1 and CB1 receptors,
DEX was applied in the presence of a cocktail of AM251 (10µM),
5′-iRFT (10µM), and the TRPV4 antagonist RN 1734 (10µM).
In the presence of these combined selective antagonists, base-
line mEPSC frequency was 5.3± 1.0 Hz (n= 5). DEX applica-
tion failed to increase mEPSC frequency at 3 min (5.5± 1.1 Hz;
p> 0.05) or decrease mEPSC frequency at 9 min (5.9± 1.2 Hz;
p> 0.05; Table 1; Figure 5) in any neuron in the presence of the
antagonists. Although a residual increase in mEPSC frequency was
observed after TRPV1/CB1 receptor blockade alone, addition of
a TRPV4 antagonist completely prevented the effects of DEX on
mEPSC frequency.
THE EFFECT OF TRPV4 AGONIST
Recent evidence suggests that AEA may modulate TRPV4 activity
in addition to TRPV1 and CB1R (Watanabe et al., 2003; Nilius
et al., 2007). Because TRPV1 and TRPV4 have similar functional
and pharmacological properties and are often co-expressed in the
same brain regions (Cohen, 2007; Nilius et al., 2007), we examined
TRPV4 activation by 4-α-PDD in gastric-related preautonomic
PVN neurons of rats and TRPV1 knockout mice to verify the pres-
ence of functional TRPV4 receptors in these animals. In rats, bath
application of 4-α-PDD (1µM) increased mEPSC frequency in
each of four cells, from 2.8± 0.5 Hz in control (range 1.6–4.3 Hz)
to 3.5± 0.6 Hz in 4-α-PDD (range 2.2–5.1 Hz, p< 0.05, n= 4)
at 3 min (Figure 5G). In TRPV1 knockout mice, bath applica-
tion of 4-α-PDD (1µM) increased mEPSC frequency in each of
six neurons, from 3.1± 1 Hz (range 0.3–6.3 Hz) to 4.2± 1.3 Hz
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FIGURE 5 | Rapid increase in mEPSC frequency in PVN gastric-related
preautonomic neurons elicited by dexamethasone (DEX) at 3min
depends onTRPV1 andTRPV4 receptors. (A,B) Sequential recordings of
mEPSCs observed in an EGFP-labeled PVN neuron at a holding potential of
−60 mV in the presence of AM251 and the selective TRPV1 (5′-iRFT) and
TRPV4 (RN1734) antagonists during control conditions (A) and after 3 min (B)
of bath application of 10µM DEX. (C,D) Expanded traces from the boxed
areas in the traces shown in (A,B). (E) Cumulative probability plots of
inter-mEPSC interval distribution from the same cell showed no significant
increase at 3 min in mEPSC frequency (p<0.02; K–S test). (F) No change in
group means in mEPSC frequency after by 10µM DEX at 3 and 9 min (n=5;
p>0.05; ANOVA, Tukey’s). (G) 4-α-PDD (1µM), a selective TRPV4 receptor
agonist, increased the mEPSC frequency in gastric-related preautonomic PVN
neurons from rat (n=4) and TRPV1 knockout mice (n= 6; p<0.05; t -test).
(range 0.6–8.3 Hz, p< 0.05; n= 6) by 3 min of drug application
(Figure 5G). Like activation of TRPV1 receptors, activation of
TRPV4 receptors also produced an increase in mEPSC frequency
in gastric-related PVN neurons.
EFFECT OF DEX ON mEPSC FREQUENCY DEPENDS ON
G-PROTEIN-MEDIATED ACTIVITY
It was shown previously that DEX-induced eCB-mediated effects
on synaptic input via a postsynaptic, G-protein-dependent effect
in PVN neurons (Di et al., 2003, 2009). To determine if the
effect of DEX on mEPSC frequency depended on G-protein-
mediated activity in the recorded gastric-related neurons, cells
were loaded intracellularly with GDP-β−S (500µM) to inhibit
G-protein function. The frequency of mEPSCs was 1.9± 0.4 Hz
in five cells loaded with GDP-β−S (Figure 6). Application of
DEX (10µM) failed to alter mEPSC frequency in any neu-
ron either during the first 3 min (1.8± 0.4 Hz; p> 0.05) or at
9 min (1.9± 0.4 Hz; p> 0.05), as determined by either the intra-
assay K–S test or repeated-measures ANOVA. Blocking G-protein
activity in recorded neurons with intracellular GDP-β−S, there-
fore, prevented the rapid excitatory and inhibitory effects of
DEX.
DISCUSSION
In this study we present evidence for a novel rapid biphasic modu-
lation by glucocorticoids and AEA of excitatory synaptic input
to a subset of identified gastric-related preautonomic neurons
in the PVN of the rat hypothalamus. This modulation occurs
via dual activation of TRPV and CB1 receptors in a subset of
neurons. To target the stomach-related preautonomic PVN neu-
rons specifically, we used the transsynaptic retrograde transport of
PRV-152, which expressed EGFP in pre-gastric neurons. Organ-
specific labeling with PRV-152 after peripheral inoculation has
been demonstrated previously (Larsen, 1999; Cano et al., 2000,
2001; Glatzer et al., 2003; Williams et al., 2007). Consistent with
previous findings (Smith et al., 2000; Irnaten et al., 2001; Davis
et al., 2003; Glatzer et al., 2003, 2007; Derbenev et al., 2004;
Williams and Smith, 2006), we did not observe any obvious
differences in the basic electrophysiological properties of PRV-
152-labeled neurons versus those reported for preautonomic PVN
neurons identified by other methods, including the presence of
low-threshold spikes that characterize these neurons (Stern, 2001;
Luther et al., 2002). Recorded PVN neurons expressing EGFP
were, therefore, likely to be preautonomic cells with polysynaptic
projections to the stomach.
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FIGURE 6 | Blockade of G-protein activity prevented DEX-induced
changes in mEPSC frequency in PVN gastric-related preautonomic
neurons. (A–C) Sequential recordings of mEPSCs observed in an
EGFP-labeled PVN neuron at a holding potential of −60 mV loaded with
the G-protein inhibitor, GDPβS, during control conditions (A), after 3 (B)
and 9 min (C) of bath application of 10µM DEX. (D–F) Expanded traces
from the boxed areas in the traces shown in (A–C). (G) Cumulative
probability plots of inter-mEPSC interval distribution from the same cell
showed no significant increase at any time in mEPSC frequency
(p>0.05; K–S test). (H) No change in group means in mEPSC
frequency after by 10µM DEX at 3 and 9 min (n=5; p>0.05; ANOVA,
Tukey’s).
ACTIVATION OF CB1 RECEPTORS
Previous data indicated that DEX activates a postsynaptic
membrane-associated receptor in PVN neurosecretory neurons,
which leads to the release of the eCBs, AEA, and 2-AG (Di et al.,
2003, 2005a; Evanson et al., 2010). Immunohistochemical evi-
dence indicates the presence of CB1R in the PVN (Cristino et al.,
2006). We observed a significant inhibition of glutamate release
in gastric-related preautonomic PVN neurons, as indicated by
a decrease in mEPSC frequency by 9 min of DEX application.
This was mimicked within a similar time frame by AEA and
WIN 55,212-2 and was abolished by the CB1 receptor antagonist
AM251. This finding is similar to observations in neuroendocrine
parvocellular and magnocellular PVN cells, where glucocorticoids
and cannabinoid agonists inhibited glutamatergic input to neu-
roendocrine cells (Di et al., 2003, 2005a). The inhibition of mEPSC
frequency was likely mediated by CB1 receptor activation, as previ-
ously reported for neuroendocrine neurons of the PVN (Di et al.,
2003, 2005b).
Whereas the enhancement of mEPSC frequency was observed
in approximately half of gastric-related PVN neurons, the DEX-
and AEA-induced decreases in mEPSC frequency were observed
in all cells. The rapid enhancement of mEPSC frequency was not
reported in neuroendocrine cells (Di et al., 2003, 2005b), which
could indicate a functional difference in the response charac-
teristics of these two cell groups. Interestingly, glucocorticoids
were shown to elicit a facilitation of GABA release onto mag-
nocellular neuroendocrine cells over several minutes, but this
was mediated by retrograde nitric oxide actions and not by acti-
vation of presynaptic TRPV receptors (Di et al., 2005b, 2009).
Thus, PVN neuron activity would be expected to be inhib-
ited over several minutes of exposure to glucocorticoids, via
suppression of glutamate release and enhancement of GABA
release.
ACTIVATION OF TRPV RECEPTORS
We also observed a significant transient increase in mEPSC fre-
quency within the first few min of DEX and AEA application in
about 50% of gastric-related preautonomic PVN neurons, which
was mimicked by capsaicin and the TRPV4-selective agonist 4-
α-PDD and was therefore most likely due to activation of TRPV
receptors. The present results are consistent with the hypothesis
that both TRPV1 and TRPV4 are functional in the nucleus. Func-
tional TRPV1 receptors have been reported in the PVN previously
(Li et al., 2004), and it is possible that glucocorticoid-mediated
release of AEA represents an endogenous means of activating
these receptors (Smart et al., 2000). The initial excitatory phase
of the biphasic response was blocked by the non-selective TRPV
antagonist ruthenium red and was eliminated in the presence of
combined antagonists to TRPV1 and TRPV4 receptors. However,
selective antagonism of TRPV1 only partially blocked the effect,
consistent with previous reports (Wenger et al., 2003; Karlsson
et al., 2005). Glutamate release was also enhanced by the TRPV4
agonist 4-α-PDD, suggesting that TRPV4 receptors contribute to
the facilitatory response to DEX and AEA (Vriens et al., 2004).
Indeed, TRPV1 receptors are present in the PVN at presynaptic
glutamatergic terminals (Mezey et al., 2000; Li et al., 2004; Cristino
et al.,2006),and TRPV4 receptors have been identified in the hypo-
thalamus (Guler et al., 2002; Carreno et al., 2009). In a subset of
gastric-related circuits, therefore, AEA or DEX act first to activate
presynaptically located TRPV receptors and enhance glutamate
release, and subsequently to activate CB1 receptors and suppress
glutamate release. In an extension of previous findings (Di et al.,
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2005b) that also showed glucocorticoid effects on synaptic release
to be prevented by blocking G-protein-mediated responses in the
recorded neuron, our data are consistent with a model in which an
eCB or other retrograde messenger is released by rapid, G-protein-
mediated glucocorticoid actions on gastric-related preautonomic
neurons in the PVN.
The TRPV receptors (TRPV1-6) are a family of ligand-gated,
non-selective cation channels with high Ca2+ permeability (Mon-
tell, 2001). They are activated by a wide range of stimuli (Nilius
et al., 2003), including thermal, mechanical, and osmotic stimuli
and endogenous lipids, including AEA, NADA, and arachidonic
acid metabolites (Watanabe et al., 2003). Capsaicin has been
demonstrated to significantly increase the frequency of mEP-
SCs (but not mIPSCs) without changing mEPSC amplitude or
decay time constant in presympathetic PVN neurons (Li et al.,
2004). These data are consistent with another study showing that
capsaicin stimulates glutamate release from hypothalamic slices
(Sasamura et al., 1998). A presynaptic effect of capsaicin on neu-
rotransmitter release was also shown in feeding-related autonomic
brainstem areas (Jin et al., 2004; Derbenev et al., 2006). Li et al.
(2004) reported that selective TRPV1 blockade prevented the
averaged effect of capsaicin, but did not report effects on indi-
vidual neurons. A recent report indicated that TRPV1-mediated
responses were restricted to liver-related preautonomic PVN neu-
rons, and that this effect was eliminated in a model of type 1
diabetes (Gao et al., 2012) due to receptor internalization. This
mechanism of diabetes-induced TRPV1 plasticity was previously
identified in gastric-related preganglionic parasympathetic motor
neurons of the dorsal motor nucleus of the vagus (Zsombok
et al., 2011). Our data indicating that TRPV1 activates inputs to
gastric-related PVN cells, in addition to liver-related cells described
previously (Gao et al., 2012), suggest that TRPV1 modulation
of glutamate release is not limited to cells regulating a specific
organ system. It is also possible that individual PVN neurons reg-
ulate more than one digestive visceral organ via the vagus nerve,
possibly via circuits within the vagal complex. However, expres-
sion of DEX-induced, TRPV-mediated excitation of glutamate
release was not ubiquitous, occurring in approximately 40–50%
of the pre-gastric neurons we recorded, which suggests that only
a subpopulation of pre-gastric neurons within the PVN contain
glucocorticoid-induced TRPV receptor activity.
We also found that the effect of capsaicin persisted in null
mutant mice lacking TRPV1, consistent with the residual effect
in the presence of TRPV1 antagonists. In these mice, and in
rats, a selective TRPV4 agonist increased mEPSC frequency. The
concept of both TRPV1 and TRPV4 operating in concert is not
surprising, since recent work suggests an involvement of TRPV1
and/or TRPV4 in osmoregulation, where a possible interaction
occurs between the receptors to mediate osmosensitivity (Sharif
Naeini et al., 2006; Cohen, 2007). Hypotonicity activates TRPV4
(Watanabe et al., 2003; Vriens et al., 2004); hypertonicity acti-
vates TRPV1, or possibly a novel TRPV1 splice variant, found
in the lamina terminalis and in magnocellular neurons of the
PVN, which is present in TRPV1-/- mice (Schumacher et al., 2000;
Ciura and Bourque, 2006; Sharif Naeini et al., 2006; Tian et al.,
2006). Our findings suggest a possible cellular mechanism by
which the TRPV receptor family (i.e., TRPV1, TRPV4) operate in
concert to maintain homeostatic autonomic functions in addition
to osmoregulation.
In addition to being eCBs, AEA, and NADA are functional
agonists at TRPV1 (Di Marzo et al., 1994; Zygmunt et al., 1999;
Smart et al., 2000). TRPV1-mediated effects of the “endocannabi-
noids” AEA and NADA have been described in the brainstem
(Derbenev et al., 2006; Sharkey et al., 2007) and the striatum
(Maccarrone et al., 2008). These results demonstrated a functional
role for TRPV1-mediated effects of eicosanoid-derived endovanil-
loids/endocannabinoids in the brain, similar to pharmacological
actions in transfected cells (van der Stelt et al., 2005). Addi-
tionally, AEA can modulate TRPV4 receptor activity indirectly
due to enzymatic hydrolysis to arachidonic acid and metabo-
lism of arachidonic acid by cytochrome p450 (Watanabe et al.,
2003), further supporting its role as an endogenous vanilloid.
Our results are consistent with the hypothesis that endocannabi-
noids/endovanilloids,after either exogenous agonist application or
endogenously induced release by DEX, can activate CB1, TRPV1,
and TRPV4 receptors in the PVN.
POSSIBLE PHYSIOLOGICAL RELEVANCE
One possible functional role for the biphasic action of DEX in
a subset of preautonomic neurons is to regulate the response
bandwidth of these cells during transitions from low to high glu-
cocorticoid levels. In neurons that are relatively quiescent prior
to glucocorticoid exposure, a reduction in excitatory input would
not be expected to have large effects. However, activation of TRPV
receptors may “prime” the system for the eventual reduction in
activity caused by CB1 receptor-mediated reduction in excitation
and subsequent orexigenic activity. Alternatively, specific synapses
may be differentially regulated by each receptor type. In either
case, rapid and transient responses in centrally projecting neu-
rons, whose activity is relayed to the next neuron in a synaptic
chain with high fidelity, may allow for immediate changes in gas-
tric modulation. Release of eCBs is thought to be “on demand”
and to correspond to increases in cellular activity (Di Marzo et al.,
1994). The transient increase in excitatory synaptic activity caused
by eCB release may result in an increase in the gain of the system,
such that the eventual inhibition of input becomes more rele-
vant to the cell than it would normally be in the absence of the
priming influence of TRPV activation. The broad regulation of
neuroendocrine PVN neurons by DEX and AEA (Di et al., 2003,
2005b, 2009; Di and Tasker, 2008), which we also now report in
preautonomic neurons, suggests a role for glucocorticoids in coor-
dinating both endocrine and autonomic output from the nucleus.
A biphasic regulation of gastric-associated outputs also provides
an increased capacity for modulation of these circuits, as well as
for plastic changes associated with different feeding-related states.
The present findings in identified gastric-related preautonomic
PVN neurons support the hypothesis that feeding and digestive
behaviors are rapidly modulated by the activity of glucocorti-
coids and AEA in the PVN and that this modulation is often
biphasic. Typically, excitation of PVN neurons is associated with
reduced feeding, while inhibition (or reduced excitation) in the
PVN enhances feeding (Grandison and Guidotti, 1977; Sims and
Lorden, 1986; Kow and Pfaff, 1989). The transient excitatory
effect of eCB release would likely suppress gastric activity whereas
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the delayed, long-term inhibitory effects would increase gastric
function relative to the previous relaxed state. The polysynap-
tic projection of these neurons to the stomach implicates them
in the autonomic regulation of gastric function, and suggests a
direct link, therefore, between the rapid modulatory actions of
glucocorticoids and eCBs and feeding/digestive behaviors.
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